Skip to content

On this page

Vimizim

elosulfase alfa

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Vimizim

Proper name

elosulfase alfa

Licence type

351(a)

BLA number

125460

Applicant

BioMarin Pharmaceutical Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
5MG/5ML (1MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	February 14, 2014

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	February 14, 2021

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity